Loading...
Linagliptin — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Linagliptin
2025-Q4
Comprehensive analysis of India’s linagliptin export trade — suppliers, buyers, prices, routes, and every shipment record.
118
Shipments
$365K
Trade Value
33
Suppliers
20
Buyers
20
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/linagliptin
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s linagliptin trade — 2025-Q4
KEY TAKEAWAY
Linagliptin 2025-Q4 exports total $364.5K across 20 countries, with MSN LABORATORIES PVT LTD commanding 45.7% market share.
TOTAL SHIPMENTS
118
2025-Q4
EXPORT VALUE
$364.5K
FOB USD
TOTAL QUANTITY
3.2M
units shipped
INDIAN SUPPLIERS
33
unique exporters
GLOBAL BUYERS
20
unique importers
DESTINATIONS
20
countries
MEDIAN UNIT PRICE
$3.72
per unit
TOP-5 SHARE
92.7%
of total USD
BRANDED SHARE
90.7%
107 shipments
DOSAGE FORMS
1
product types
6 KEY FINDINGS
1
MSN LABORATORIES PVT LTD is India's #1 Linagliptin exporter with $166.7K (45.7% market share).→ §5, Indian Supplier Rankings
2
Linagliptin reached 20 countries, with United States as the top destination ($120.5K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 2953) — top 10 suppliers control 97.7% of exports.→ §5, Indian Supplier Rankings
4
80.0% of buyers (16 of 20) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (99.8%) across 1 dosage forms.→ §7, Price Benchmarks
6
20 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 MSN LABORATORIES PVT LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian linagliptin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Linagliptin report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial linagliptin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian linagliptin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Linagliptin India trade report
Product scope
Linagliptin
All variants merged — branded and generic formulations of linagliptin
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
118
Every commercial linagliptin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a v-curve: Oct $199.6K, Nov $21.5K, Dec $143.4K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$199.6K
Oct USD
20 shipments
2
$21.5K
Nov USD
-89.2% MoM
3
$143.4K
Dec USD
+568.0% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 89.2% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $200K, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $365K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $178K dip in Nov, $122K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $200K | 20 shipments |
| Nov | $21K | 57 shipments |
| Dec | $143K | 41 shipments |
| Q4 Total | $365K | 118 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Mauritius held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MSN LABORATORIES PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import linagliptin from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 33.1% of India’s 2025-Q4 linagliptin trade ($120.5K). Beyond the top 10 destinations, 20 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 9 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 20 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much linagliptin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$72K
19.6% of trade
5 countries · 69 shipments
Americas
$188K
51.6% of trade
5 countries · 17 shipments
Africa
$105K
28.7% of trade
9 countries · 31 shipments
Oceania
$12
0.0% of trade
1 countries · 1 shipments
Fig 4.1 United States is the #1 corridor ($121K) — 20 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian linagliptin it receives (light = low, dark = high). Orange arcs radiate from India to the top 20 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $121K | 7 | MSN LABORATORIES PVT LTD | $121K | — | — | — | — |
| 2 | Angola | $92K | 4 | INVEX HEALTH PVT LTD | $92K | — | — | — | — |
| 3 | Philippines | $49K | 2 | LOB INTERNATIONAL | $49K | — | — | — | — |
| 4 | Guatemala | $46K | 4 | MSN LABORATORIES PVT LTD | $46K | — | — | — | — |
| 5 | Brazil | $21K | 1 | INTAS PHARMACEUTICALS LTD | $21K | — | — | — | — |
| 6 | Thailand | $16K | 3 | SHAIMIL LABORATORIES | $10K | TENCH LIFE SCIENCES LLP | $7K | MEDREICH LTD | $2 |
| 7 | United Arab Emirates | $5K | 61 | LAWRENCE WALTER | $4K | DERRIC WOOD | $908 | GAIA TRADE PVT LTD | $745 |
| 8 | Mauritius | $5K | 7 | SAVA HEALTHCARE LTD | $3K | PLEASANT EXPORTS | $2K | HEXA HEALTH CARE PVT LTD | $114 |
| 9 | Lesotho | $3K | 1 | ACT LIFESCIENCES PVT LTD | $3K | — | — | — | — |
| 10 | Somalia | $3K | 7 | SANJEEVANI BIO-TECH EXIM PVT LTD | $1K | RMPL PHARMA LLP | $1K | AZKA MEDTRADE AND SERVICES | $126 |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 19.6% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
33.1%
#1 country share
United States alone
90.1%
Top 5 share
5 of 20 countries
99.8%
Top 15 share
Long tail of 5 countries = 0.2%
HHI 2128
Destination HHI
Moderately concentrated
20
Countries served
Global pharma reach from India
9
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
33 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
MSN LABORATORIES PVT LTD ($166.7K, 45.7% share) and INVEX HEALTH PVT LTD ($92.1K) together control 71.0% of India’s 2025-Q4 linagliptin trade. The top 5 suppliers hold 92.7%. 33 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian linagliptin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 MSN LABORATORIES PVT LTD leads by $75K over INVEX HEALTH PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: DERRIC WOOD is #13 by value but #2 by volume.
Fig 5.2 LAWRENCE WALTER also leads by shipment count (33) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: DERRIC WOOD moves from #2 by volume to #13 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 33 linagliptin suppliers split into strategic segments
KEY TAKEAWAY
9 suppliers (25%) generate 97.1% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 MSN LABORATORIES PVT LTD and INVEX HEALTH PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 97.1% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PVT LTD | 1 | 2 | $167K |
| 2 | INVEX HEALTH PVT LTD | 1 | 1 | $92K |
| 3 | LOB INTERNATIONAL | 1 | 1 | $49K |
| 4 | INTAS PHARMACEUTICALS LTD | 1 | 1 | $21K |
| 5 | SHAIMIL LABORATORIES | 1 | 1 | $10K |
| 6 | TENCH LIFE SCIENCES LLP | 1 | 1 | $7K |
| 7 | LAWRENCE WALTER | 1 | 1 | $4K |
| 8 | ACT LIFESCIENCES PVT LTD | 1 | 1 | $3K |
| 9 | SAVA HEALTHCARE LTD | 1 | 1 | $3K |
| 10 | PLEASANT EXPORTS | 1 | 1 | $2K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the linagliptin manufacturing hubs
KEY TAKEAWAY
Hyderabad and Mumbai together account for $309K of India’s 2025-Q4 linagliptin trade.
Fig 5.5 Hyderabad (1 exporters, $167K) and Mumbai (9 exporters, $142K) are India’s linagliptin capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
92.7%
Top 5 share
5 of 33 suppliers
97.7%
Top 10 share
10 of 33 suppliers
97.1%
Top 25% share
9 suppliers = 97% USD
HHI 2953
Supplier HHI
Concentrated
33
Total suppliers
shipped Linagliptin in 2025-Q4
20+ cities
Indian hubs
Hyderabad and Mumbai lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | MSN LABORATORIES PVT LTD | $167K |
#1
EXPORTER PROFILE #1 OF 1
MSN LABORATORIES PVT LTD
Hyderabad · India’s #1 linagliptin supplier by USD · 2025-Q4
2025-Q4 USD
$167K
45.7% market share
SHIPMENTS
11
avg $15K/ship
COUNTRIES
2
destination markets
BUYERS
2
2 single-sourced
BRANDED
100%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
United States is the #1 market at $121K (72% of trade), followed by Guatemala at $46K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $121K | 7 | 72.3% |
| 2 | Guatemala | $46K | 4 | 27.7% |
MONTHLY TREND
Oct peaked at $121K. Nov was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| NOVADOZ PHARMACEUTICAL… | United States | $121K | ⚠ Locked |
| GETICS SOCIEDAD ANONIMA | Guatemala | $46K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
MSN LABORATORIES PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 United States absorbs $121K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
20 importers across 20 countries — who is buying Indian linagliptin and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 18 importers together hold only 96.5% of total USD. 80% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian linagliptin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 NOVADOZ PHARMACEUTICALS LLC is the #1 importer at $121K (33.1%) — top 18 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 18 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
80%
Single-source
16 buyers rely on exactly 1 Indian supplier
5%
Dual-source
1 buyers use 2 Indian suppliers
10%
Multi-source (3–4)
2 buyers diversified across 3–4
5%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source linagliptin from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Thailand 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| VITAL PHARMACEUTICALS … | SHAIMIL LABORATORIES | $10K | $2.379 | Tablet |
| THAI MEIJI PHARMACEUTI… | MEDREICH LTD | $2.429 | $2.429 | Tablet |
Seychelles 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| CENTRAL POINT PHARMACY | NALIINI.R.EXPORT PVT… | $124.783 | $4.159 | Tablet |
| MINISTRY OF HEALTH | HLL LIFECARE LTD | $4.992 | $0.0010 | Tablet |
United States 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| NOVADOZ PHARMACEUTICAL… | MSN LABORATORIES PVT… | $121K | $0.112 | Tablet |
Angola 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| CAPITAL PHARMA CARE | INVEX HEALTH PVT LTD | $92K | $0.554 | Tablet |
Philippines 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| KHRIZ PHARMA TRADING INC | LOB INTERNATIONAL | $49K | $0.977 | Tablet |
§6.3 Price positioning — top 18 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | NOVADOZ PHARMACEUTIC… | United States | $121K | $17K | Mid |
| 2 | CAPITAL PHARMA CARE | Angola | $92K | $23K | Mid |
| 3 | KHRIZ PHARMA TRADING… | Philippines | $49K | $24K | Mid |
| 4 | GETICS SOCIEDAD ANON… | Guatemala | $46K | $12K | Budget |
| 5 | ACCORD FARMACUTICA L… | Brazil | $21K | $21K | Mid |
| 6 | VITAL PHARMACEUTICAL… | Thailand | $10K | $10K | Budget |
| 7 | EMIRATES POST COMPANY | United Arab Emirates | $5K | $86.000 | Budget |
| 8 | NATIONAL DRUG SERVIC… | Lesotho | $3K | $3K | Budget |
| 9 | REGENCY EXIM TRADE LTD | Mauritius | $3K | $679.000 | Budget |
| 10 | ZAPATERO INTERNATION… | Mauritius | $2K | $1K | Budget |
| 11 | GALAXY PHARMACEUTICA… | Kenya | $549.760 | $550.000 | Budget |
| 12 | RAHUL PHARMA | Nepal | $480.990 | $481.000 | Budget |
| 13 | THE PHARMACIST | Cayman Islands | $177.341 | $89.000 | Budget |
| 14 | CENTRAL POINT PHARMACY | Seychelles | $124.783 | $125.000 | Budget |
| 15 | FREIGHTER MADE LOGIS… | Ghana | $59.433 | $59.000 | Budget |
| 16 | TO THEORDER OF QUEST… | Fiji | $12.029 | $12.000 | Budget |
| 17 | MINISTRY OF HEALTH | Seychelles | $4.992 | $5.000 | Budget |
| 18 | THAI MEIJI PHARMACEU… | Thailand | $2.429 | $2.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 18 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 MSN LABORATORIES PVT LTD → NOVADOZ PHARMACEUTICALS LLC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 18 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian linagliptin prices vary by supplier, country and dosage form
KEY TAKEAWAY
Linagliptin prices span 4604× ($0.0092 → $42.37). The coefficient of variation is 1.34. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0092 | Lowest observed unit price |
| P5 | $0.030 | 5th percentile |
| P25 | $0.358 | 25th percentile (Q1) |
| Median | $3.72 | 50th percentile (Q2) |
| P75 | $11.40 | 75th percentile (Q3) |
| P95 | $30.18 | 95th percentile |
| Max | $42.37 | Highest observed unit price |
| Mean | $8.76 | Arithmetic average |
| CV | 134% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 ACT LIFESCIENCES PVT LTD prices at $37.96/unit vs market median $3.72.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. MSN LABORATORIES PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. LAWRENCE WALTER Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. INTAS PHARMACEUTICALS LTD Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. SHAIMIL LABORATORIES Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | MEDINEX HEALTHCARE | Mexico | Tablet | 10 | $490.33 | $49.03 | Specialty / small-batch |
| Dec 2025 | GAIA TRADE PVT LTD | United Arab Emirates | Tablet | 1 | $42.37 | $42.37 | Specialty / small-batch |
| Dec 2025 | GAIA TRADE PVT LTD | United Arab Emirates | Tablet | 2 | $78.76 | $39.38 | Specialty / small-batch |
| Dec 2025 | GAIA TRADE PVT LTD | United Arab Emirates | Tablet | 2 | $78.76 | $39.38 | Specialty / small-batch |
| Nov 2025 | ACT LIFESCIENCES… | Lesotho | Tablet | 80 | $3K | $37.96 | Specialty / small-batch |
| Dec 2025 | LAWRENCE WALTER | United Arab Emirates | Tablet | 1 | $30.81 | $30.81 | Specialty / small-batch |
| Dec 2025 | LAWRENCE WALTER | United Arab Emirates | Tablet | 2 | $60.39 | $30.20 | Specialty / small-batch |
| Nov 2025 | LAWRENCE WALTER | United Arab Emirates | Tablet | 4 | $120.70 | $30.18 | Specialty / small-batch |
| Nov 2025 | LAWRENCE WALTER | United Arab Emirates | Tablet | 1 | $30.16 | $30.16 | Specialty / small-batch |
| Nov 2025 | LAWRENCE WALTER | United Arab Emirates | Tablet | 16 | $482.46 | $30.15 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Oct 2025 | MSN LABORATORIES… | United States | Tablet | 214K | $2K | $0.0092 | Bulk generic tablet |
| Dec 2025 | MDS ENTERPRISES | United Arab Emirates | Tablet | 10 | $0.129 | $0.013 | Small sample / trial shipment |
| Oct 2025 | MSN LABORATORIES… | United States | Tablet | 12K | $188.76 | $0.016 | |
| Oct 2025 | MSN LABORATORIES… | United States | Tablet | 43K | $697.28 | $0.016 | |
| Dec 2025 | GMSANJIVANI LLP | Somalia | Tablet | 300 | $6.49 | $0.022 | Small sample / trial shipment |
| Oct 2025 | INTAS PHARMACEUT… | Brazil | Tablet | 876K | $21K | $0.024 | |
| Dec 2025 | MDS ENTERPRISES | United Arab Emirates | Tablet | 100 | $3.42 | $0.034 | Small sample / trial shipment |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 45 | $1.71 | $0.038 | Small sample / trial shipment |
| Dec 2025 | MSN LABORATORIES… | Guatemala | Tablet | 76K | $3K | $0.046 | |
| Dec 2025 | MSN LABORATORIES… | Guatemala | Tablet | 330K | $15K | $0.046 |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship linagliptin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Linagliptin leaves India through 12+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), HYDERABAD AIR, HYDERABAD ICD) handle 95.0% of total USD. SEA moves 9% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $148K — top 12 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 CHICAGO O'HARE INT'L is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 9% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$168K
46.2% of USD · 9.3% of ships
AIR
$138K
37.8% of USD · 83.9% of ships
ICD
$58K
15.8% of USD · 5.9% of ships
ROAD
$481
0.1% of USD · 0.8% of ships
Fig 8.3 The dominant corridor is HYDERABAD AIR → Air → N. America ($121K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
United States is the most concentrated destination (HHI 10000, 1 suppliers). Somalia is the most competitive (HHI 4593).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 United States (HHI 10,000) is the most concentrated — Somalia (HHI 4,593) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| NOVADOZ PHARMACEUTIC… | United States | MSN LABORATORIES… | $121K | 7 | HIGH |
| CAPITAL PHARMA CARE | Angola | INVEX HEALTH PVT… | $92K | 4 | MEDIUM |
| KHRIZ PHARMA TRADING… | Philippines | LOB INTERNATIONAL | $49K | 2 | MEDIUM |
| GETICS SOCIEDAD ANON… | Guatemala | MSN LABORATORIES… | $46K | 4 | MEDIUM |
| ACCORD FARMACUTICA L… | Brazil | INTAS PHARMACEUT… | $21K | 1 | MEDIUM |
| VITAL PHARMACEUTICAL… | Thailand | SHAIMIL LABORATO… | $10K | 1 | MEDIUM |
| NATIONAL DRUG SERVIC… | Lesotho | ACT LIFESCIENCES… | $3K | 1 | MEDIUM |
| ZAPATERO INTERNATION… | Mauritius | PLEASANT EXPORTS | $2K | 2 | MEDIUM |
Conclusion: 16 buyers depend on exactly one Indian supplier, representing $344K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|---|---|---|---|---|
| EMIRATES POST COMPANY | United Arab Emirates | 3 | $5K | LAWRENCE WALTER | MEDIUM |
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Angola | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Philippines | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Guatemala | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Thailand | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mauritius | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lesotho | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Somalia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Singapore | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Mexico | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United States | This Q | HIGH |
| A2 | Offer alternative to EMIRATES POST | This Q | HIGH |
| A3 | Audit United States lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter United States (1 suppliers) | This Q | HIGH |
| A6 | Enter Angola (1 suppliers) | This Q | MED |
| A8 | Build Angola distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | United States | Other | 1 | $121K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Angola | Africa | 1 | $92K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Philippines | Asia | 1 | $49K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Guatemala | Other | 1 | $46K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Brazil | Other | 1 | $21K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Thailand | Asia | 3 | $16K | -100% | LOW | Low competition (3 suppliers), accessible market |
| 7 | Mauritius | Africa | 3 | $5K | +29% | LOW | Growing 29% with only 3 competitors |
| 8 | United Arab Emirates | Other | 4 | $5K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 9 | Lesotho | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Somalia | Africa | 4 | $3K | -94.8% | LOW | Low competition (4 suppliers), accessible market |
| 11 | Nigeria | Africa | 2 | $1K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Singapore | Asia | 1 | $602 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Kenya | Africa | 1 | $550 | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Mexico | Other | 1 | $490 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Nepal | Asia | 1 | $481 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 118 2025-Q4 Linagliptin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/linagliptin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 118 2025-Q4 linagliptin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian linagliptin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
118
across all regions
TOTAL USD
$365K
2025-Q4 FOB value
UNITS
3.2M
tablets, capsules, etc.
SUPPLIERS
33
Indian exporters
BUYERS
20
global importers
COUNTRIES
20
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $105K (28.7%), spanning 9 countries.
33 Indian suppliers shipped to 20 buyers across 20 countries — average shipment value $3K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
9 countries · 31 shipments · $105K · 17 Indian suppliers · 10 buyers
SHIPMENTS
31
USD
$105K
COUNTRIES
9
SUPPLIERS
17
BUYERS
10
HHI
7,750
concentrated
Top 9 destination countries in Africa
1
Angola (87.9%)
$92K
2
Mauritius (4.6%)
$5K
3
Lesotho (2.9%)
$3K
4
Somalia (2.5%)
$3K
5
Nigeria (1.0%)
$1K
6
Kenya (0.5%)
$549.76
7
Ghana (0.4%)
$370.94
8
Seychelles (0.1%)
$129.78
9
Zimbabwe (0.0%)
$32.78
Top 17 Indian suppliers into Africa
1
INVEX HEALTH PVT LTD
$92K
2
ACT LIFESCIENCES PVT LTD
$3K
3
SAVA HEALTHCARE LTD
$3K
4
PLEASANT EXPORTS
$2K
5
SANJEEVANI BIO-TECH EXIM PVT LTD
$1K
6
RMPL PHARMA LLP
$1K
7
POOJA PHARMACEUTICAL
$729.99
8
SAI TECH MEDICARE PVT LTD
$549.76
9
KLV HEALTHCARE PVT LTD
$340.00
10
MDS ENTERPRISES
$311.51
11
AZKA MEDTRADE AND SERVICES
$125.74
12
NALIINI.R.EXPORT PVT LTD
$124.78
13
HEXA HEALTH CARE PVT LTD
$114.00
14
BAKER & DAVIS PVT LTD
$59.43
15
RUTVA MEDICARE
$32.78
16
GMSANJIVANI LLP
$6.49
17
HLL LIFECARE LTD
$4.99
Top 8 Africa importers
1
CAPITAL PHARMA CARE · Angola
$92K
2
NATIONAL DRUG SERVICE ORGANIZATION · Lesotho
$3K
3
REGENCY EXIM TRADE LTD · Mauritius
$3K
4
ZAPATERO INTERNATIONAL LTD · Mauritius
$2K
5
GALAXY PHARMACEUTICALS LTD · Kenya
$549.76
6
CENTRAL POINT PHARMACY · Seychelles
$124.78
7
FREIGHTER MADE LOGISTICS LTD · Ghana
$59.43
8
MINISTRY OF HEALTH · Seychelles
$4.99
Top 2 dosage forms
1
Tablet
$104K
2
Unknown
$742.02
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 7 | $3K | $413.31 |
| Nov | 12 | $6K | $481.95 |
| Dec | 12 | $96K | $8K |
Shipment register · 31 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — INVEX HEALTH PVT LTD · 4 shipments · $92K | |||||||||||
| 1 | Dec 2025 | CAPITAL PHARMA CARE | Angola | Tablet | 10.6K | NOS | $0.554 | $6K | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| 2 | Dec 2025 | CAPITAL PHARMA CARE | Angola | Tablet | 59.5K | NOS | $0.554 | $33K | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| 3 | Dec 2025 | CAPITAL PHARMA CARE | Angola | Tablet | 59.5K | NOS | $0.554 | $33K | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| 4 | Dec 2025 | CAPITAL PHARMA CARE | Angola | Tablet | 36.7K | NOS | $0.554 | $20K | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| SUPPLIER #2 — ACT LIFESCIENCES PVT LTD · 1 shipments · $3K | |||||||||||
| 5 | Nov 2025 | NATIONAL DRUG SERVICE ORGANIZATION | Lesotho | Tablet | 80 | NOS | $37.96 | $3K | MUMBAI AIR (SAHAR) | MASERU | AIR |
| SUPPLIER #3 — SAVA HEALTHCARE LTD · 3 shipments · $3K | |||||||||||
| 6 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 33 | NOS | $0.328 | $10.84 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 7 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 89 | NOS | $29.40 | $3K | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 8 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 1 | NOS | $29.39 | $29.39 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #4 — PLEASANT EXPORTS · 2 shipments · $2K | |||||||||||
| 9 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 700 | NOS | $1.40 | $978.67 | CHENNAI AIR | MAURITIUS | AIR |
| 10 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 900 | NOS | $1.20 | $1K | CHENNAI AIR | MAURITIUS | AIR |
| SUPPLIER #5 — SANJEEVANI BIO-TECH EXIM PVT LTD · 1 shipments · $1K | |||||||||||
| 11 | Nov 2025 | UNLISTED BUYER | Somalia | Tablet | 3.9K | NOS | $0.358 | $1K | AHMEDABAD ICD | MOGADISHU | ICD |
| SUPPLIER #6 — RMPL PHARMA LLP · 4 shipments · $1K | |||||||||||
| 12 | Nov 2025 | UNLISTED BUYER | Somalia | Tablet | 117 | NOS | $3.11 | $363.43 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 13 | Nov 2025 | UNLISTED BUYER | Somalia | Tablet | 63 | NOS | $3.11 | $195.69 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 14 | Nov 2025 | UNKNOWN BUYER | Somalia | Tablet | 117 | NOS | $3.11 | $363.43 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 15 | Nov 2025 | UNKNOWN BUYER | Somalia | Tablet | 63 | NOS | $3.11 | $195.69 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #7 — POOJA PHARMACEUTICAL · 2 shipments · $729.99 | |||||||||||
| 16 | Nov 2025 | UNLISTED BUYER | Nigeria | Tablet | 3.3K | PCS | $0.0000 | $0.0000 | DELHI AIR | LAGOS | AIR |
| 17 | Dec 2025 | UNLISTED BUYER | Nigeria | 3.3K | PCS | $0.220 | $729.99 | DELHI AIR | LAGOS | AIR | |
| SUPPLIER #8 — SAI TECH MEDICARE PVT LTD · 1 shipments · $549.76 | |||||||||||
| 18 | Oct 2025 | GALAXY PHARMACEUTICALS LTD | Kenya | Tablet | 1.0K | NOS | $0.550 | $549.76 | LUDHIANA ICD | MOMBASA | ICD |
| SUPPLIER #9 — KLV HEALTHCARE PVT LTD · 2 shipments · $340.00 | |||||||||||
| 19 | Dec 2025 | UNLISTED BUYER | Nigeria | Tablet | 2.0K | NOS | $0.080 | $160.00 | DELHI AIR | LAGOS | AIR |
| 20 | Dec 2025 | UNLISTED BUYER | Nigeria | Tablet | 2.0K | NOS | $0.090 | $180.00 | DELHI AIR | LAGOS | AIR |
| SUPPLIER #10 — MDS ENTERPRISES · 2 shipments · $311.51 | |||||||||||
| 21 | Nov 2025 | UNLISTED BUYER | Ghana | Tablet | 20 | NOS | $2.44 | $48.85 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 22 | Dec 2025 | UNLISTED BUYER | Ghana | Tablet | 100 | NOS | $2.63 | $262.65 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #11 — AZKA MEDTRADE AND SERVICES · 1 shipments · $125.74 | |||||||||||
| 23 | Oct 2025 | UNLISTED BUYER | Somalia | Tablet | 100 | NOS | $1.26 | $125.74 | NHAVA SHEVA SEA (JNPT) | Mogadishu | SEA |
| SUPPLIER #12 — NALIINI.R.EXPORT PVT LTD · 1 shipments · $124.78 | |||||||||||
| 24 | Oct 2025 | CENTRAL POINT PHARMACY | Seychelles | Tablet | 30 | NOS | $4.16 | $124.78 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #13 — HEXA HEALTH CARE PVT LTD · 2 shipments · $114.00 | |||||||||||
| 25 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 5 | NOS | $11.40 | $57.00 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 26 | Nov 2025 | UNKNOWN BUYER | Mauritius | Tablet | 5 | NOS | $11.40 | $57.00 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #14 — BAKER & DAVIS PVT LTD · 1 shipments · $59.43 | |||||||||||
| 27 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 850 | NOS | $0.070 | $59.43 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #15 — RUTVA MEDICARE · 2 shipments · $32.78 | |||||||||||
| 28 | Oct 2025 | UNLISTED BUYER | Zimbabwe | Tablet | 9 | PCS | $2.31 | $20.75 | AHMEDABAD AIR | HARARE | AIR |
| 29 | Oct 2025 | UNLISTED BUYER | Zimbabwe | 20 | PCS | $0.601 | $12.03 | AHMEDABAD AIR | HARARE | AIR | |
| SUPPLIER #16 — GMSANJIVANI LLP · 1 shipments · $6.49 | |||||||||||
| 30 | Dec 2025 | UNLISTED BUYER | Somalia | Tablet | 300 | NOS | $0.022 | $6.49 | MUMBAI AIR (SAHAR) | MOGADISCHU | AIR |
| SUPPLIER #17 — HLL LIFECARE LTD · 1 shipments · $4.99 | |||||||||||
| 31 | Nov 2025 | MINISTRY OF HEALTH | Seychelles | Tablet | 5.0K | NOS | $0.0010 | $4.99 | DELHI AIR | MAHE ISLAND | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
5 countries · 69 shipments · $72K · 10 Indian suppliers · 7 buyers
SHIPMENTS
69
USD
$72K
COUNTRIES
5
SUPPLIERS
10
BUYERS
7
HHI
4,923
concentrated
Top 5 destination countries in Asia
1
Philippines (68.0%)
$49K
2
Thailand (22.8%)
$16K
3
United Arab Emirates (7.7%)
$5K
4
Singapore (0.8%)
$602.06
5
Nepal (0.7%)
$480.99
Top 10 Indian suppliers into Asia
1
LOB INTERNATIONAL
$49K
2
SHAIMIL LABORATORIES
$10K
3
TENCH LIFE SCIENCES LLP
$7K
4
LAWRENCE WALTER
$4K
5
DERRIC WOOD
$907.90
6
GAIA TRADE PVT LTD
$744.59
7
VINAYAK ASSOCIATES
$602.06
8
MICRO LABS LTD
$480.99
9
MDS ENTERPRISES
$3.55
10
MEDREICH LTD
$2.43
Top 5 Asia importers
1
KHRIZ PHARMA TRADING INC · Philippines
$49K
2
VITAL PHARMACEUTICALS CO LTD · Thailand
$10K
3
EMIRATES POST COMPANY · United Arab Emirates
$5K
4
RAHUL PHARMA · Nepal
$480.99
5
THAI MEIJI PHARMACEUTICAL CO LTD · Thailand
$2.43
Top 2 dosage forms
1
Tablet
$71K
2
Unknown
$77.13
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 4 | $55K | $14K |
| Nov | 44 | $16K | $353.90 |
| Dec | 21 | $626.71 | $29.84 |
Shipment register · 69 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — LOB INTERNATIONAL · 2 shipments · $49K | |||||||||||
| 1 | Oct 2025 | KHRIZ PHARMA TRADING INC | Philippines | Tablet | 25.3K | NOS | $0.977 | $25K | NHAVA SHEVA SEA (JNPT) | Manila North Harbor | SEA |
| 2 | Oct 2025 | KHRIZ PHARMA TRADING INC | Philippines | Tablet | 24.5K | NOS | $0.977 | $24K | NHAVA SHEVA SEA (JNPT) | Manila North Harbor | SEA |
| SUPPLIER #2 — SHAIMIL LABORATORIES · 1 shipments · $10K | |||||||||||
| 3 | Nov 2025 | VITAL PHARMACEUTICALS CO LTD | Thailand | Tablet | 4.0K | NOS | $2.38 | $10K | AHMEDABAD ICD | LAEM CHABANG | ICD |
| SUPPLIER #3 — TENCH LIFE SCIENCES LLP · 1 shipments · $7K | |||||||||||
| 4 | Oct 2025 | UNLISTED BUYER | Thailand | Tablet | 13.0K | NOS | $0.515 | $7K | NHAVA SHEVA SEA (JNPT) | Laem Chabang | SEA |
| SUPPLIER #4 — LAWRENCE WALTER · 33 shipments · $4K | |||||||||||
| 5 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $27.47 | $494.50 | DELHI AIR | DUBAI | AIR |
| 6 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $27.47 | $27.47 | DELHI AIR | DUBAI | AIR |
| 7 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $10.59 | $21.17 | DELHI AIR | DUBAI | AIR |
| 8 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $10.59 | $10.59 | DELHI AIR | DUBAI | AIR |
| 9 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $11.02 | $11.02 | DELHI AIR | DUBAI | AIR |
| 10 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $11.02 | $22.05 | DELHI AIR | DUBAI | AIR |
| 11 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $27.47 | $494.50 | DELHI AIR | DUBAI | AIR |
| 12 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $27.47 | $27.47 | DELHI AIR | DUBAI | AIR |
| 13 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $10.59 | $21.17 | DELHI AIR | DUBAI | AIR |
| 14 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $10.59 | $10.59 | DELHI AIR | DUBAI | AIR |
| 15 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $11.02 | $11.02 | DELHI AIR | DUBAI | AIR |
| 16 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $11.02 | $22.05 | DELHI AIR | DUBAI | AIR |
| 17 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 21 | PCS | $27.72 | $582.07 | DELHI AIR | DUBAI | AIR |
| 18 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 3 | PCS | $27.72 | $83.15 | DELHI AIR | DUBAI | AIR |
| 19 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $11.84 | $11.84 | DELHI AIR | DUBAI | AIR |
| 20 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 21 | PCS | $27.72 | $582.07 | DELHI AIR | DUBAI | AIR |
| 21 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 3 | PCS | $27.72 | $83.15 | DELHI AIR | DUBAI | AIR |
| 22 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 1 | PCS | $11.84 | $11.84 | DELHI AIR | DUBAI | AIR |
| 23 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 8 | PCS | $29.86 | $238.86 | DELHI AIR | DUBAI | AIR |
| 24 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $30.16 | $30.16 | DELHI AIR | DUBAI | AIR |
| 25 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $17.30 | $34.61 | DELHI AIR | DUBAI | AIR |
| 26 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 16 | PCS | $30.15 | $482.46 | DELHI AIR | DUBAI | AIR |
| 27 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 4 | PCS | $30.18 | $120.70 | DELHI AIR | DUBAI | AIR |
| 28 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $30.04 | $180.22 | DELHI AIR | DUBAI | AIR |
| 29 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $30.15 | $60.30 | DELHI AIR | DUBAI | AIR |
| 30 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 3 | PCS | $11.62 | $34.85 | DELHI AIR | DUBAI | AIR |
| 31 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $30.20 | $60.39 | DELHI AIR | DUBAI | AIR |
| 32 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $17.69 | $17.69 | DELHI AIR | DUBAI | AIR |
| 33 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $30.81 | $30.81 | DELHI AIR | DUBAI | AIR |
| 34 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.337 | $0.674 | DELHI AIR | DUBAI | AIR |
| 35 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 4 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 36 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 4 | PCS | $0.337 | $1.35 | DELHI AIR | DUBAI | AIR |
| 37 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 5 | PCS | $0.337 | $1.68 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #5 — DERRIC WOOD · 14 shipments · $907.90 | |||||||||||
| 38 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $3.74 | $33.69 | DELHI AIR | DUBAI | AIR |
| 39 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $3.75 | $33.73 | DELHI AIR | DUBAI | AIR |
| 40 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $3.75 | $33.73 | DELHI AIR | DUBAI | AIR |
| 41 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 15 | PCS | $3.73 | $55.95 | DELHI AIR | DUBAI | AIR |
| 42 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $3.73 | $33.54 | DELHI AIR | DUBAI | AIR |
| 43 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $3.73 | $33.54 | DELHI AIR | DUBAI | AIR |
| 44 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $3.72 | $22.34 | DELHI AIR | DUBAI | AIR |
| 45 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $3.72 | $22.34 | DELHI AIR | DUBAI | AIR |
| 46 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 72 | PCS | $3.93 | $283.15 | DELHI AIR | DUBAI | AIR |
| 47 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 72 | PCS | $3.93 | $283.15 | DELHI AIR | DUBAI | AIR |
| 48 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $3.94 | $35.42 | DELHI AIR | DUBAI | AIR |
| 49 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 45 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 50 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 45 | PCS | $0.038 | $1.71 | DELHI AIR | DUBAI | AIR |
| 51 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $3.96 | $35.61 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #6 — GAIA TRADE PVT LTD · 12 shipments · $744.59 | |||||||||||
| 52 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | NOS | $4.25 | $38.21 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 53 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 36 | NOS | $4.25 | $152.86 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 54 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | NOS | $4.28 | $38.54 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 55 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | 18 | NOS | $4.29 | $77.13 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR | |
| 56 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | NOS | $4.29 | $77.22 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 57 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | NOS | $42.37 | $42.37 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 58 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 36 | NOS | $4.38 | $157.61 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 59 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 36 | NOS | $0.049 | $1.76 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 60 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | NOS | $0.483 | $0.483 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 61 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | NOS | $0.440 | $0.879 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | SEA |
| 62 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | NOS | $39.38 | $78.76 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 63 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | NOS | $39.38 | $78.76 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| SUPPLIER #7 — VINAYAK ASSOCIATES · 2 shipments · $602.06 | |||||||||||
| 64 | Nov 2025 | UNLISTED BUYER | Singapore | Tablet | 2.2K | PCS | $0.139 | $308.32 | DELHI AIR | SINGAPORE | AIR |
| 65 | Nov 2025 | UNLISTED BUYER | Singapore | Tablet | 2.2K | PCS | $0.132 | $293.73 | DELHI AIR | SINGAPORE | AIR |
| SUPPLIER #8 — MICRO LABS LTD · 1 shipments · $480.99 | |||||||||||
| 66 | Nov 2025 | RAHUL PHARMA | Nepal | Tablet | 510 | NOS | $0.943 | $480.99 | RAXAUL | Birgunj | ROAD |
| SUPPLIER #9 — MDS ENTERPRISES · 2 shipments · $3.55 | |||||||||||
| 67 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 100 | NOS | $0.034 | $3.42 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| 68 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 10 | NOS | $0.013 | $0.129 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| SUPPLIER #10 — MEDREICH LTD · 1 shipments · $2.43 | |||||||||||
| 69 | Oct 2025 | THAI MEIJI PHARMACEUTICAL CO LTD | Thailand | Tablet | 1 | NOS | $2.43 | $2.43 | BANGALORE AIR | BANGKOK | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
5 countries · 17 shipments · $188K · 6 Indian suppliers · 6 buyers
SHIPMENTS
17
USD
$188K
COUNTRIES
5
SUPPLIERS
6
BUYERS
6
HHI
7,965
concentrated
Top 5 destination countries in Americas
1
United States (64.0%)
$121K
2
Guatemala (24.5%)
$46K
3
Brazil (11.1%)
$21K
4
Mexico (0.3%)
$490.33
5
Cayman Islands (0.1%)
$183.53
Top 6 Indian suppliers into Americas
1
MSN LABORATORIES PVT LTD
$167K
2
INTAS PHARMACEUTICALS LTD
$21K
3
MEDINEX HEALTHCARE
$490.33
4
KALINDI OVERSEAS
$177.34
5
ZYPHARS PHARMACEUTICS PVT LTD
$4.45
6
SMN OVERSEAS
$1.74
Top 4 Americas importers
1
NOVADOZ PHARMACEUTICALS LLC · United States
$121K
2
GETICS SOCIEDAD ANONIMA · Guatemala
$46K
3
ACCORD FARMACUTICA LTDA · Brazil
$21K
4
THE PHARMACIST · Cayman Islands
$177.34
Top 1 dosage forms
1
Tablet
$188K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 8 | $141K | $18K |
| Nov | 1 | $116.46 | $116.46 |
| Dec | 8 | $47K | $6K |
Shipment register · 17 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MSN LABORATORIES PVT LTD · 11 shipments · $167K | |||||||||||
| 1 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 175.2K | NOS | $0.146 | $26K | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 2 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 53.6K | NOS | $0.143 | $8K | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 3 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 345.6K | NOS | $0.146 | $50K | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 4 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 232.9K | NOS | $0.146 | $34K | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 5 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 214.2K | NOS | $0.0092 | $2K | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 6 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 42.8K | NOS | $0.016 | $697.28 | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 7 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 11.9K | NOS | $0.016 | $188.76 | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 8 | Dec 2025 | GETICS SOCIEDAD ANONIMA | Guatemala | Tablet | 75.6K | NOS | $0.046 | $3K | HYDERABAD ICD | PUERTO QUETZAL | ICD |
| 9 | Dec 2025 | GETICS SOCIEDAD ANONIMA | Guatemala | Tablet | 288.4K | NOS | $0.046 | $13K | HYDERABAD ICD | PUERTO QUETZAL | ICD |
| 10 | Dec 2025 | GETICS SOCIEDAD ANONIMA | Guatemala | Tablet | 330.4K | NOS | $0.046 | $15K | HYDERABAD ICD | PUERTO QUETZAL | ICD |
| 11 | Dec 2025 | GETICS SOCIEDAD ANONIMA | Guatemala | Tablet | 307.8K | NOS | $0.046 | $14K | HYDERABAD ICD | PUERTO QUETZAL | ICD |
| SUPPLIER #2 — INTAS PHARMACEUTICALS LTD · 1 shipments · $21K | |||||||||||
| 12 | Oct 2025 | ACCORD FARMACUTICA LTDA | Brazil | Tablet | 876.5K | TBS | $0.024 | $21K | MUNDRA SEA | Santos | SEA |
| SUPPLIER #3 — MEDINEX HEALTHCARE · 1 shipments · $490.33 | |||||||||||
| 13 | Dec 2025 | UNLISTED BUYER | Mexico | Tablet | 10 | NOS | $49.03 | $490.33 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #4 — KALINDI OVERSEAS · 2 shipments · $177.34 | |||||||||||
| 14 | Nov 2025 | THE PHARMACIST | Cayman Islands | Tablet | 18 | NOS | $6.47 | $116.46 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| 15 | Dec 2025 | THE PHARMACIST | Cayman Islands | Tablet | 9 | NOS | $6.76 | $60.88 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| SUPPLIER #5 — ZYPHARS PHARMACEUTICS PVT LTD · 1 shipments · $4.45 | |||||||||||
| 16 | Dec 2025 | UNKNOWN BUYER | Cayman Islands | Tablet | 12 | NOS | $0.371 | $4.45 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| SUPPLIER #6 — SMN OVERSEAS · 1 shipments · $1.74 | |||||||||||
| 17 | Dec 2025 | UNLISTED BUYER | Cayman Islands | Tablet | 36 | NOS | $0.048 | $1.74 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $12.03 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$12.03
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Fiji (100.0%)
$12.03
Top 1 Indian suppliers into Oceania
1
MEDIPAAMS INDIA PVT LTD
$12.03
Top 1 Oceania importers
1
TO THEORDER OF QUEST PHARMACY MAIN · Fiji
$12.03
Top 1 dosage forms
1
Tablet
$12.03
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $12.03 | $12.03 |
| Nov | 0 | $0.0000 | — |
| Dec | 0 | $0.0000 | — |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MEDIPAAMS INDIA PVT LTD · 1 shipments · $12.03 | |||||||||||
| 1 | Oct 2025 | TO THEORDER OF QUEST PHARMACY MAIN | Fiji | Tablet | 10 | NOS | $1.20 | $12.03 | NHAVA SHEVA SEA (JNPT) | Lautoka | SEA |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 33 Indian linagliptin exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped linagliptin in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | MSN LABORATORIES PVT LTD | HYDERABAD | 11 | $167K | Tablet | Americas |
| 2 | INVEX HEALTH PVT LTD | MUMBAI | 4 | $92K | Tablet | Africa |
| 3 | LOB INTERNATIONAL | MUMBAI | 2 | $49K | Tablet | Asia |
| 4 | INTAS PHARMACEUTICALS LTD | AHMEDABAD | 1 | $21K | Tablet | Americas |
| 5 | SHAIMIL LABORATORIES | VADODARA | 1 | $10K | Tablet | Asia |
| 6 | TENCH LIFE SCIENCES LLP | SURAT | 1 | $7K | Tablet | Asia |
| 7 | LAWRENCE WALTER | DELHI | 33 | $4K | Tablet | Asia |
| 8 | ACT LIFESCIENCES PVT LTD | VASHI | 1 | $3K | Tablet | Africa |
| 9 | SAVA HEALTHCARE LTD | PUNE | 3 | $3K | Tablet | Africa |
| 10 | PLEASANT EXPORTS | CHENNAI | 2 | $2K | Tablet | Africa |
| 11 | SANJEEVANI BIO-TECH EXIM PVT LTD | AHMEDABAD | 1 | $1K | Tablet | Africa |
| 12 | RMPL PHARMA LLP | MUMBAI | 4 | $1K | Tablet | Africa |
| 13 | DERRIC WOOD | SUBHASH PLACE | 14 | $907.90 | Tablet | Asia |
| 14 | GAIA TRADE PVT LTD | SOUTH GOA | 12 | $744.59 | Tablet | Asia |
| 15 | POOJA PHARMACEUTICAL | AMBALA CANTT | 2 | $729.99 | Tablet | Africa |
| 16 | VINAYAK ASSOCIATES | DELHI | 2 | $602.06 | Tablet | Asia |
| 17 | SAI TECH MEDICARE PVT LTD | KALA AMB | 1 | $549.76 | Tablet | Africa |
| 18 | MEDINEX HEALTHCARE | Mumbai | 1 | $490.33 | Tablet | Americas |
| 19 | MICRO LABS LTD | PATNA | 1 | $480.99 | Tablet | Asia |
| 20 | KLV HEALTHCARE PVT LTD | DAHISAR | 2 | $340.00 | Tablet | Africa |
| 21 | MDS ENTERPRISES | MUMBAI | 4 | $315.05 | Tablet | Africa, Asia |
| 22 | KALINDI OVERSEAS | MUMBAI | 2 | $177.34 | Tablet | Americas |
| 23 | AZKA MEDTRADE AND SERVICES | MUMBAI | 1 | $125.74 | Tablet | Africa |
| 24 | NALIINI.R.EXPORT PVT LTD | CHENNAI | 1 | $124.78 | Tablet | Africa |
| 25 | HEXA HEALTH CARE PVT LTD | MUMBAI. | 2 | $114.00 | Tablet | Africa |
| 26 | BAKER & DAVIS PVT LTD | MUMBAI | 1 | $59.43 | Tablet | Africa |
| 27 | RUTVA MEDICARE | SURAT | 2 | $32.78 | Tablet | Africa |
| 28 | MEDIPAAMS INDIA PVT LTD | MUMBAI | 1 | $12.03 | Tablet | Oceania |
| 29 | GMSANJIVANI LLP | Bhiwandi | 1 | $6.49 | Tablet | Africa |
| 30 | HLL LIFECARE LTD | UTTAR PRADESH | 1 | $4.99 | Tablet | Africa |
| 31 | ZYPHARS PHARMACEUTICS PVT LTD | PUNE | 1 | $4.45 | Tablet | Americas |
| 32 | MEDREICH LTD | BENGALURU | 1 | $2.43 | Tablet | Asia |
| 33 | SMN OVERSEAS | PALGHAR | 1 | $1.74 | Tablet | Americas |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 18 global linagliptin importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian linagliptin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | NOVADOZ PHARMACEUTICALS LLC | United States | 7 | $121K | MSN LABORATORIES PVT… | Tablet |
| 2 | CAPITAL PHARMA CARE | Angola | 4 | $92K | INVEX HEALTH PVT LTD | Tablet |
| 3 | KHRIZ PHARMA TRADING INC | Philippines | 2 | $49K | LOB INTERNATIONAL | Tablet |
| 4 | GETICS SOCIEDAD ANONIMA | Guatemala | 4 | $46K | MSN LABORATORIES PVT… | Tablet |
| 5 | ACCORD FARMACUTICA LTDA | Brazil | 1 | $21K | INTAS PHARMACEUTICAL… | Tablet |
| 6 | VITAL PHARMACEUTICALS CO LTD | Thailand | 1 | $10K | SHAIMIL LABORATORIES | Tablet |
| 7 | EMIRATES POST COMPANY | United Arab Emirates | 56 | $5K | LAWRENCE WALTER | Tablet |
| 8 | NATIONAL DRUG SERVICE ORGANIZATION | Lesotho | 1 | $3K | ACT LIFESCIENCES PVT… | Tablet |
| 9 | REGENCY EXIM TRADE LTD | Mauritius | 4 | $3K | SAVA HEALTHCARE LTD | Tablet |
| 10 | ZAPATERO INTERNATIONAL LTD | Mauritius | 2 | $2K | PLEASANT EXPORTS | Tablet |
| 11 | GALAXY PHARMACEUTICALS LTD | Kenya | 1 | $549.76 | SAI TECH MEDICARE PV… | Tablet |
| 12 | RAHUL PHARMA | Nepal | 1 | $480.99 | MICRO LABS LTD | Tablet |
| 13 | THE PHARMACIST | Cayman Islands | 2 | $177.34 | KALINDI OVERSEAS | Tablet |
| 14 | CENTRAL POINT PHARMACY | Seychelles | 1 | $124.78 | NALIINI.R.EXPORT PVT… | Tablet |
| 15 | FREIGHTER MADE LOGISTICS LTD | Ghana | 1 | $59.43 | BAKER & DAVIS PVT LTD | Tablet |
| 16 | TO THEORDER OF QUEST PHARMACY MAIN | Fiji | 1 | $12.03 | MEDIPAAMS INDIA PVT … | Tablet |
| 17 | MINISTRY OF HEALTH | Seychelles | 1 | $4.99 | HLL LIFECARE LTD | Tablet |
| 18 | THAI MEIJI PHARMACEUTICAL CO LTD | Thailand | 1 | $2.43 | MEDREICH LTD | Tablet |
This report covers 118 2025-Q4 Linagliptin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/linagliptin
Talk to our trade analyst
Need a custom linagliptin report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/linagliptin
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Linagliptin product page
Live data, supplier directory, price trends, and trade route analysis